H2 saline reduces myocardial apoptosisScientific Research


original title: Pharmacological post-conditioning with lactic acid and saturated hydrogen saline could attenuate myocardial apoptosis

Authors:

Guoming Zhang, K Liu, X Li, L Xu, Y Sun, H Tan, H Shen, X Wang

DOI: 10.3760/cma.j.issn.1671-0282.2015.03.014

-

Abstract:

Objective: To study the hypothesis about the pharmacological post-conditioning with lactic acid and saturated hydrogen saline after ischemic injury of myocardium instead of post-conditioning with mechanical dilatation of severely occluded coronary vessels to attenuate apoptosis of cardiocyte by mitogenactivated protein kinases (MAPK) pathway.

Methods: A total of 108 rats were randomly (random number) divided into 6 groups (re = 18 in each group): sham operated group (received 60 pX normal saline without ischemia), reperfusion/injury group (R/I, received 60 pX normal saline solution and routine ischemicreperfusion [IR] procedure), post-conditioning group (M-Post, received 60 pX normal saline and postconditioning treatment, 4 cycles of 20/20 s of reperfusion/re-occlusion), lactic acid group (Lac, received 60 |xL lactic acid and routine IR procedure), saturated hydrogen saline group (Hyd, received 60 pX hydrogen rich saline and routine IR procedure), and lactic acid + saturated hydrogen saline group (Lac + Hyd, received a combination of 60 pX of lactic acid and 60 μL of hydrogen rich saline along with routine IR procedure). Acute myocardial infarction model was made by ischemia for 45 min, and pH value of blood from right atrium was detected in rats of all groups. After 3 min reperfusion, 6 rats of each group were sacrificed and myocardial tissue was taken out to measure the level of MDA and SOD. After 30 min reperfusion, other 6 rats of each group were sacrificed and myocardial tissue was taken out to measure the level of phosphorylated MAPK (p38/JNK and ERK), TNF-a, Caspase-8 by Western-blot method. After 24 h reperfusion, there were only 6 rats in each group, and hemodynamics were measured in each rat, and then rats were sacrificed and hearts were taken out to detect cell apoptosis by TUNEL method. A one-way analysis of variance (ANOVA) was used, and q tests were employed to determine if any significant differences in individual variable existed between groups.

Results: The pH of blood from right atrium after 3 min of reperfusion in Lac + Hyd group was significantly lower than that in R/I group (7. 32 ±0. 06 vs. 7. 43 ±0. 03, P <0. 05), the content of MDA was lower (1. 14 ± 0.16 vs. 1. 56 ± 0. 21, P < 0. 05) and the content of SOD was higher in Lac + Hyd group than those in R/I group (57. 92 ± 15. 12 vs. 35. 48 ± 12. 46, P < 0. 05). Apoptotic index of Lac + Hyd group was much lower than that of R/I group (9. 50 ± 1. 51) % vs. (15. 21 ± 1.91)%, P<0.05. After 30 min of reperfusion, the level of P-p38 in ischemic myocardia in Lac + Hyd group was significantly lower than that in R/I group (0. 46 ±0. 06 vs. 2. 18 ±0. 32, P <0. 05), the levels of P-JNK (0.59 ±0.03 vs. 1.62 ±0.29, P<0.05), TNFa (0.34 ±0.08 vs. 1.78 ±0.31, P<0.05) and Caspase-8 (0. 31 ±0. 07 vs. 1. 52 ± 0. 28, P < 0. 05) were all lower than those in R/I group. However, there were no significant differences in levels of all above variables between Lac + Hyd group and M-Post group (P > 0. 05). After 30 min of reperfusion, there was no significant difference in the level of P-ERK between Lac + Hyd group and R/I group (0. 55 ± 0. 13 vs. 0. 57 ± 0. 05, P > 0. 05), and the level of P-ERK in Hyd group was significantly lower than that in R/I group (0. 30 ± 0. 09 vs. 0. 57 ± 0. 05, P < 0. 05), And the level of P-ERK in Lac Hyd and Lac + Hyd groups was significantly lower than that in M-Post group (1.21 ± 0.13, 0. 30 ± 0.09, 0. 55 ± 0.13 vs. 1. 96 ± 0. 39, P < 0.05).

Conclusion: Pharmacological post-conditioning with lactic acid and saturated hydrogen saline could be used instead of mechanical post-conditioning to inhibit the phosphorylation of p38/JNK and ERK, attenuating myocardial cell apoptosis.

Hydrogen Therapy At Home

Beyond clinical settings, hydrogen therapy is successfully used at home — thanks to our internationally recognised devices.

At “Hydrogen Technologies” Ltd., for more than 15 years we have been developing and manufacturing “HHO Bulgaria” devices for health with hydrogen.

We are among the pioneers in the field and, unlike many of our competitors worldwide, we continue to exist and to innovate!

By choosing “HHO Bulgaria”, you support both your own health and Bulgarian innovation and manufacturing.

Meet HBS10 — Europe’s best-selling hydrogen therapy device, both in Bulgaria and worldwide.

HBS10 — Hydrogen therapy device

HBS10 → More about HBS10 TOP PRODUCT

Inhalation and water

H2 therapy device
2-in-1

Output

Hydrogen inhalation
450 ml
HHO gas per minute

Concentration

Hydrogen water
-250 mV
ORP

The device is a 2-in-1 system: use it for hydrogen inhalation or to prepare hydrogen-rich water (“hydrogen water”).

HBS10 is the only European hydrogen therapy device chromatographically tested for safety at the Bulgarian Academy of Sciences (BAS)!

In addition, the device is:

  • CE certified;
  • Tested and recommended by the renowned hydrogen therapy platform H2HUBB, USA.

Order online

H2BOOSTR Mini is our newest alternative for hydrogen therapy at home.

H2BOOSTR Mini — hydrogen water system with 100% pure molecular hydrogen

H2BOOSTR Mini → More about H2BOOSTR NEW

100% pure molecular hydrogen

100%
pure molecular
hydrogen

Ready in 30 seconds

30 seconds
to prepare

High hydrogen concentration

3.2–3.6 mg
hydrogen
per litre of water

The system saturates water with 100% pure molecular hydrogen (“hydrogen water” with maximum dissolved hydrogen).

H2BOOSTR Mini reflects Bulgarian innovation: the technology is fully engineered in Bulgaria and is the world’s only solution that prepares one litre of hydrogen water in just 30 seconds with over 3 ppm of 100% pure molecular hydrogen!

Order online

FREE PERSONAL
CONSULTATION

  • SHORT AND
    STRAIGHT TO THE POINT
  • SPECIFIC
    TO YOUR NEEDS
  • CLEAR, AND IN
    EASY-TO-UNDERSTAND LANGUAGE

Discover How Molecular Hydrogen Therapy
can help You
and Your Loved Ones.

Ask The World's First Specialized H2 Consultant,
equipped with knowledge acquired from:

1400+

Clinical Studies,
Scientific Reports and Publications
conducted Worldwide

Analyses, consultations and summaries, prepared and published on our websites by Medical Specialists:

  • Dr. Ivan Vlasov
  • Dr. Victoria Kaludova
Sylvia Panayotova - H2 Consultant

Trained by:

Sylvia
Panayotova

Hydrogen Therapy Consultant,
certified by the Molecular Hydrogen
Institute (MHI) in the U.S.